These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9434921)

  • 21. Activation of coagulation occurs after electrical cardioversion in patients with chronic atrial fibrillation despite optimal anticoagulation with warfarin.
    Jacob K; Talwar S; Copplestone A; Gilbert TJ; Haywood GA
    Int J Cardiol; 2004 May; 95(1):83-8. PubMed ID: 15159043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [D-dimer, thrombin-antithrombin III-complex (TAT) and prothrombin fragment 1+2 (PTF). Parameters for monitoring therapy with low molecular-weight heparin in coagulation disorders].
    Hofmann M; Rest A; Hafner G; Tanner B; Brockerhoff P; Weilemann LS
    Anaesthesist; 1997 Aug; 46(8):689-96. PubMed ID: 9382207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant human transgenic antithrombin in cardiac surgery: a dose-finding study.
    Levy JH; Despotis GJ; Szlam F; Olson P; Meeker D; Weisinger A
    Anesthesiology; 2002 May; 96(5):1095-102. PubMed ID: 11981148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Turnover study of prothrombin, antithrombin III and fibrinogen in patients with liver cirrhosis.
    Saitoh H; Kobayashi N; Maekawa T
    Nihon Ketsueki Gakkai Zasshi; 1986 Sep; 49(6):1263-74. PubMed ID: 3811789
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacokinetic behaviour of antithrombin III following intravenous infusion in healthy volunteers.
    Marzo A; Ceppi-Monti N; Giusti A; Abbiati G; Parenti M
    Arzneimittelforschung; 2002; 52(3):187-93. PubMed ID: 11963646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
    Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
    Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Markers of coagulation activation after hepatic resection for cancer: evidence of sustained upregulation of coagulation.
    Weinberg L; Scurrah N; Parker FC; Dauer R; Marshall J; McCall P; Story D; Smith C; McNicol L
    Anaesth Intensive Care; 2011 Sep; 39(5):847-53. PubMed ID: 21970128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The suprapharmacologic dosing of antithrombin concentrate for Staphylococcus aureus-induced disseminated intravascular coagulation in guinea pigs: substantial reduction in mortality and morbidity.
    Kessler CM; Tang Z; Jacobs HM; Szymanski LM
    Blood; 1997 Jun; 89(12):4393-401. PubMed ID: 9192763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of low and high dose oral contraceptives on blood coagulation and thrombogenesis induced by vascular subendothelium exposed to flowing human blood.
    Inauen W; Stocker G; Haeberli A; Straub PW
    Contraception; 1991 May; 43(5):435-46. PubMed ID: 1833126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of antithrombin and gabexate mesilate on disseminated intravascular coagulation: a preliminary study.
    Nishiyama T; Kohno Y; Koishi K
    Am J Emerg Med; 2012 Sep; 30(7):1219-23. PubMed ID: 22204993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High dose of intravenous antithrombin III without heparin in the treatment of disseminated intravascular coagulation and organ failure in four children.
    Fuse S; Tomita H; Yoshida M; Hori T; Igarashi C; Fujita S
    Am J Hematol; 1996 Sep; 53(1):18-21. PubMed ID: 8813091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prophylactic fibrinogen infusion in cardiac surgery patients: effects on biomarkers of coagulation, fibrinolysis, and platelet function.
    Karlsson M; Ternström L; Hyllner M; Baghaei F; Skrtic S; Jeppsson A
    Clin Appl Thromb Hemost; 2011 Aug; 17(4):396-404. PubMed ID: 20530054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of the clotting system during extracorporeal membrane oxygenation in term newborn infants.
    Urlesberger B; Zobel G; Zenz W; Kuttnig-Haim M; Maurer U; Reiterer F; Riccabona M; Dacar D; Gallisti S; Leschnik B; Muntean W
    J Pediatr; 1996 Aug; 129(2):264-8. PubMed ID: 8765625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of the coagulation cascade in patients with leptospirosis.
    Chierakul W; Tientadakul P; Suputtamongkol Y; Wuthiekanun V; Phimda K; Limpaiboon R; Opartkiattikul N; White NJ; Peacock SJ; Day NP
    Clin Infect Dis; 2008 Jan; 46(2):254-60. PubMed ID: 18171258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of antithrombin by protein SV-IV normalizes the coagulation of hemophilic blood.
    Di Micco B; Caen J; Colonna G; Macalello MA; Marchese M; Stiuso P; Di Micco P; Morelli F; Metafora S
    Eur J Pharmacol; 2000 Mar; 391(1-2):1-9. PubMed ID: 10720629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of heparin treatment on biochemical markers of an activation of the coagulation system.
    Amelsberg A; Zurborn KH; Gärtner U; Kiehne KH; Preusse AK; Bruhn HD
    Thromb Res; 1992 May; 66(2-3):121-31. PubMed ID: 1412188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
    Flather MD; Weitz JI; Yusuf S; Pogue J; Sussex B; Campeau J; Gill J; Schuld R; Joyner CD; Morris AL; Lai C; Théroux P; Marquis JF; Chan YK; Venkatesh G; Jessel A
    Eur Heart J; 2000 Sep; 21(17):1473-81. PubMed ID: 10952840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The coagulation/fibrinolysis balance in systemic sclerosis: evidence for a haematological stress syndrome.
    Ames PR; Lupoli S; Alves J; Atsumi T; Edwards C; Iannaccone L; Khamashta MA; Hughes GR; Brancaccio V
    Br J Rheumatol; 1997 Oct; 36(10):1045-50. PubMed ID: 9374919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antithrombin III concentrate use in patients with cirrhosis with coagulation disorders].
    Ribeiro AA; Lourenço DM; Toledo CF; Noguti MA; Borges DR
    Rev Assoc Med Bras (1992); 1997; 43(3):189-94. PubMed ID: 9497544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improvement in coagulation markers with antithrombin--beneficial in severe sepsis?
    Wiedermann CJ
    Crit Care Med; 2004 Sep; 32(9):1968-9. PubMed ID: 15343032
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.